Synergistic anticancer activity of disulfiram/copper against mouse lymphoma cells

نویسندگان

چکیده

Disulfiram (DSF) is a marketed drug to treat patients with alcohol dependence by inhibiting aldehyde dehydrogenase. Over the last few decades, DSF has been shown have anticancer effects through different mechanisms. Moreover, this effect can be elevated when used copper (Cu). Subsequent studies conducted on various cancers, but lymphoma. This study investigated of lymphoma and how changed treated Cu. synergistically decreased metabolic activity EL4 cells combined At 1 µM alone, 49% compared control, whereas it 87% + CuCl2 treatment. Rhodamine 123 2',7'–dichlorofluorescein diacetate staining showed that induced reduction mitochondrial membrane potential promoted production reactive oxygen species. In particular, treatment Cu cell death based multiple assays, including annexin V-fluorescein isothiocyanate/propidium iodide staining. Overall, exhibits synergistic provides some valuable information broaden use in clinics basic research.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Anticarcinogenic Activity of Leptadenia reticulata against Dalton’s Ascitic Lymphoma

The aim of the present study is to evaluate the effect of ethanolic extract of leaves of Leptadenia reticulata leaves (LELR) against Dalton’s Ascitic Lymphoma (DAL) in Swiss Albino mice. DAL cells were injected intraperitoneally (106 cells/mouse) to the mice. Two days after cells injection the animals were treated with 200 mg/kg of LELR for 8 days. Five-fluorouracil (20 mg/kg) was used ...

متن کامل

Synergistic anticancer effects of Pam3CSK4 and Ara-C on B-cell lymphoma cells.

PURPOSE The low immunogenicity of many cancer cells and the immunosuppression by various cancers and anticancer therapies have been an obstacle in the development of efficacious immunotherapies. Our goal was to test whether Toll-like receptor (TLR) agonists and anticancer chemotherapeutic agents synergize in rendering tumor cells more immunogenic. EXPERIMENTAL DESIGN We treated B-cell lymphom...

متن کامل

Cancer Therapy: Preclinical Synergistic Anticancer Effects of Pam3CSK4 and Ara-C on B-Cell Lymphoma Cells

Purpose: The low immunogenicity of many cancer cells and the immunosuppression by various cancers and anticancer therapies have been an obstacle in the development of efficacious immunotherapies. Our goal was to test whether Toll-like receptor (TLR) agonists and anticancer chemotherapeutic agents synergize in rendering tumor cells more immunogenic. Experimental Design: We treated B-cell lymphom...

متن کامل

ICG-001 Exerts Potent Anticancer Activity Against Uveal Melanoma Cells

Purpose Uveal melanoma (UM) is uniformly refractory to all available systemic chemotherapies, thus creating an urgent need for novel therapeutics. In this study, we investigated the sensitivity of UM cells to ICG-001, a small molecule reported to suppress the Wnt/β-catenin-mediated transcriptional program. Methods We used a panel of UM cell lines to examine the effects of ICG-001 on cellular ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Korean journal of veterinary research

سال: 2022

ISSN: ['2466-1384', '2466-1392']

DOI: https://doi.org/10.14405/kjvr.20210040